S.Africa’s regulator approves Pfizer COVID-19 shot for children 12 and up

JOHANNESBURG, Sept 11 (Reuters) – South Africa’s health regulator has authorized Pfizer’s (PFE.N) COVID-19 vaccine for use by children aged 12 and older, paving a approach for a supervision to offer vaccinations to teenagers.

The South African Health Products Authority (SAPHRA) pronounced a preference came after a examination of updated reserve and efficiency information submitted in Mar this year.

After a rough start, South Africa’s vaccination debate has ramped adult in new months with a plain supply of shots cumulative and only over 12% of a some-more than 60 million people vaccinated. That puts a nation good forward of others on a continent.

However, health insurers contend vaccine hesitation is now a categorical emanate impacting a gait of a debate and a supervision has launched efforts to convince people to get a jab.

South Africa has a vast girl population, with some 28% underneath a age of 15.

Countries around a universe are now deliberation or administering vaccines to children, while other vaccine developers including Moderna (MRNA.O) are seeking a immature light for a use of their shots on teens.

Pfizer, whose shot is already being administered to teens, is formulation tests on even younger children.

Our Standards: The Thomson Reuters Trust Principles.

You must be logged in to post a comment Login

Widgetized Section

Go to Admin » appearance » Widgets » and move a widget into Advertise Widget Zone